Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBIT Margin (2016 - 2025)

iBio (IBIO) has disclosed EBIT Margin for 16 consecutive years, with 5951.0% as the latest value for Q3 2025.

  • Quarterly EBIT Margin changed N/A to 5951.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 8491.0% through Dec 2025, down 434167.0% year-over-year, with the annual reading at 4650.5% for FY2025, 274239.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 5951.0% at iBio, down from 2599.0% in the prior quarter.
  • The five-year high for EBIT Margin was 377.11% in Q1 2022, with the low at 10206.0% in Q3 2023.
  • Average EBIT Margin over 5 years is 3597.2%, with a median of 2209.5% recorded in 2024.
  • Peak annual rise in EBIT Margin hit 329176bps in 2021, while the deepest fall reached -453146bps in 2021.
  • Over 5 years, EBIT Margin stood at 6220.24% in 2021, then soared by 94bps to 377.11% in 2022, then plummeted by -2606bps to 10206.0% in 2023, then soared by 78bps to 2209.5% in 2024, then plummeted by -169bps to 5951.0% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 5951.0%, 2599.0%, and 2209.5% for Q3 2025, Q2 2025, and Q4 2024 respectively.